Bladder Recurrence Following the Treatment of Upper Tract Urothelial Carcinoma
Objective: Although, upper tract urothelial carcinoma (UTUC) is rare it is associated with a high mortality rate and frequently, followed by bladder recurrence after radical surgery. Hence, this study aimed to identify the rate of bladder recurrence and its predictive factors. Material and Methods:...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Prince of Songkla University
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8431370ab37643cf964583a055583376 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8431370ab37643cf964583a055583376 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8431370ab37643cf964583a0555833762021-11-25T08:25:12ZBladder Recurrence Following the Treatment of Upper Tract Urothelial Carcinoma2586-99812630-055910.31584/jhsmr.2021807https://doaj.org/article/8431370ab37643cf964583a0555833762021-11-01T00:00:00Zhttps://www.jhsmr.org/index.php/jhsmr/article/view/807https://doaj.org/toc/2586-9981https://doaj.org/toc/2630-0559Objective: Although, upper tract urothelial carcinoma (UTUC) is rare it is associated with a high mortality rate and frequently, followed by bladder recurrence after radical surgery. Hence, this study aimed to identify the rate of bladder recurrence and its predictive factors. Material and Methods: We reviewed the medical records of 104 patients, who were diagnosed with UTUC and had radical nephroureterectomy (RNU), at the King Chulalongkorn Memorial Hospital. We excluded patients who have concurrent bladder cancer, or had a history of bladder cancer. Various clinicopathological factors were analyzed using the log-rank test and Cox proportional hazard model. Results: The mean age at diagnosis of UTUC was 68 years, and one-third of the patients were diagnosed with pathological T3 (33.7%). The mean follow-up duration was 56 months. Bladder recurrence occurred in 39 out of 104 patients (37.5%), and the median time to recurrence was 5.8 months (interquartile range 3.6 to 11.0 months). Tumor location in the distal ureter (p-value=0.038) and history of diagnostic ureteroscopy (p-value=0.004) were significantly associated with bladder recurrence in the univariate model. However, only the history of diagnostic ureteroscopy remained significant in the multivariate analysis (p-value=0.023). Conclusion: Bladder recurrence, following RNU, occurs in one-third of patients. Potential predictive factors may include history of diagnostic ureteroscopy, and the tumor location being in the distal ureter.Takarn ItsaranujareankulKanrapee NuwatkrisinKamol PanumatrassameeDutsadee SowanthipJulin OpanuraksSupoj RatchanonApirak SantingamkunManint UsawachintachitPrince of Songkla Universityarticlebladder recurrencenephroureterectomyupper tract urothelial carcinomaMedicineRENJournal of Health Science and Medical Research (JHSMR), Vol 40, Iss 1, Pp 1-9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
bladder recurrence nephroureterectomy upper tract urothelial carcinoma Medicine R |
spellingShingle |
bladder recurrence nephroureterectomy upper tract urothelial carcinoma Medicine R Takarn Itsaranujareankul Kanrapee Nuwatkrisin Kamol Panumatrassamee Dutsadee Sowanthip Julin Opanuraks Supoj Ratchanon Apirak Santingamkun Manint Usawachintachit Bladder Recurrence Following the Treatment of Upper Tract Urothelial Carcinoma |
description |
Objective: Although, upper tract urothelial carcinoma (UTUC) is rare it is associated with a high mortality rate and frequently, followed by bladder recurrence after radical surgery. Hence, this study aimed to identify the rate of bladder recurrence and its predictive factors.
Material and Methods: We reviewed the medical records of 104 patients, who were diagnosed with UTUC and had radical nephroureterectomy (RNU), at the King Chulalongkorn Memorial Hospital. We excluded patients who have concurrent bladder cancer, or had a history of bladder cancer. Various clinicopathological factors were analyzed using the log-rank test and Cox proportional hazard model.
Results: The mean age at diagnosis of UTUC was 68 years, and one-third of the patients were diagnosed with pathological T3 (33.7%). The mean follow-up duration was 56 months. Bladder recurrence occurred in 39 out of 104 patients (37.5%), and the median time to recurrence was 5.8 months (interquartile range 3.6 to 11.0 months). Tumor location in the distal ureter (p-value=0.038) and history of diagnostic ureteroscopy (p-value=0.004) were significantly associated with bladder recurrence in the univariate model. However, only the history of diagnostic ureteroscopy remained significant in the multivariate analysis (p-value=0.023).
Conclusion: Bladder recurrence, following RNU, occurs in one-third of patients. Potential predictive factors may include history of diagnostic ureteroscopy, and the tumor location being in the distal ureter. |
format |
article |
author |
Takarn Itsaranujareankul Kanrapee Nuwatkrisin Kamol Panumatrassamee Dutsadee Sowanthip Julin Opanuraks Supoj Ratchanon Apirak Santingamkun Manint Usawachintachit |
author_facet |
Takarn Itsaranujareankul Kanrapee Nuwatkrisin Kamol Panumatrassamee Dutsadee Sowanthip Julin Opanuraks Supoj Ratchanon Apirak Santingamkun Manint Usawachintachit |
author_sort |
Takarn Itsaranujareankul |
title |
Bladder Recurrence Following the Treatment of Upper Tract Urothelial Carcinoma |
title_short |
Bladder Recurrence Following the Treatment of Upper Tract Urothelial Carcinoma |
title_full |
Bladder Recurrence Following the Treatment of Upper Tract Urothelial Carcinoma |
title_fullStr |
Bladder Recurrence Following the Treatment of Upper Tract Urothelial Carcinoma |
title_full_unstemmed |
Bladder Recurrence Following the Treatment of Upper Tract Urothelial Carcinoma |
title_sort |
bladder recurrence following the treatment of upper tract urothelial carcinoma |
publisher |
Prince of Songkla University |
publishDate |
2021 |
url |
https://doaj.org/article/8431370ab37643cf964583a055583376 |
work_keys_str_mv |
AT takarnitsaranujareankul bladderrecurrencefollowingthetreatmentofuppertracturothelialcarcinoma AT kanrapeenuwatkrisin bladderrecurrencefollowingthetreatmentofuppertracturothelialcarcinoma AT kamolpanumatrassamee bladderrecurrencefollowingthetreatmentofuppertracturothelialcarcinoma AT dutsadeesowanthip bladderrecurrencefollowingthetreatmentofuppertracturothelialcarcinoma AT julinopanuraks bladderrecurrencefollowingthetreatmentofuppertracturothelialcarcinoma AT supojratchanon bladderrecurrencefollowingthetreatmentofuppertracturothelialcarcinoma AT apiraksantingamkun bladderrecurrencefollowingthetreatmentofuppertracturothelialcarcinoma AT manintusawachintachit bladderrecurrencefollowingthetreatmentofuppertracturothelialcarcinoma |
_version_ |
1718413568719716352 |